Nutrient modulation of cellular insulin action

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 187-203

  Patti, Mary Elizabeth ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FATTY ACID; GLUCOSAMINE; GLUCOSE; GLYCOGEN SYNTHASE; HEXOSAMINE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; CELL ENERGY; CELL STIMULATION; COMPETITIVE INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DIET; ENZYME ACTIVATION; ENZYME SPECIFICITY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC REGULATION; NONHUMAN; NUTRIENT; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 0032804629     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07796.x     Document Type: Conference Paper

References (69)

1. 1. Colditz, G. A., W. C. Willett, A. Rotnitzky & J. E. Manson. 1995. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 122: 481-486.
2. 2. Carey, V. J., E. E. Walters, G. A. Colditz, C. G. Solomon, W. C. Willett, B. A. Rosner, F. E. Speizer & J. E. Manson. 1997. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am. J. Epidemiol. 145: 614-619.
3. 3. Helmrich, S. P., D. R. Ragland, R. W. Leung & R. S. J. Paffenbarger. 1991. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 325: 147-152.
4. 4. Edwards, K. L., C. M. Burchfiel, D. S. Sharp, J. D. Curb, B. L. Rodriguez, W. Y. Fujimoto, A. Z. LaCroix, M. V. Vitiello & M. A. Austin. 1998. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am. J. Epidemiol. 147: 441-447.
5. 5. Fujimoto, W. Y. 1996. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet. Med. 13: S7-10.
6. 6. Pratley, R. E. 1998. Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians. Proc. Nutr. Soc. 57: 175-181.
7. 7. Ravussin, E., M. E. Valencia, J. Esparza, P. H. Bennett & L. O. Schulz. 1994. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 17: 1067-1074.
8. 8. Zimmet, P., R. Taylor, P. Ram. H. King, G. Sloman, L. R. Raper & D. Hunt. 1983. Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am. J. Epidemiol. 118: 673-688.
9. 9. Boden, G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10.
10. 10. Boden, G., X. Chen, J. Ruiz, J. V. White & L. Rossetti. 1994. Mechanisms of fatty acids induced inhibition of glucose uptake. J. Clin. Invest. 93: 2438-2446.
11. 11. Roden, M., T. B. Price, G. Perseghin, K. F. Petersen, D. L. Rothman, G. W. Cline & G. I. Shulman. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97: 2859-2865.
12. 12. Gumbiner, B., J. F. Mucha, J. E. Lindstrom, J. Rekhi & J. N. Livingston. 1996. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation. Am. J. Physiol. 270: E424-E429.
13. 13. Rebrin, K., G. M. Steil, L. Getty & R. N. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045.
14. 14. Sindelar, D. K., C. A. Chu, M. Rohlie, D. W. Neal, L. L. Swift & A. D. Cherrington. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196.
15. 15. Massillon, D., N. Barzilai, M. Hawkins, D. Prus-Wertheimer & L. Rossetti. 1997. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion [published erratum appears in Diabetes. 1997. 46(3): 536]. Diabetes 46: 153-157.
16. 16. Randle, P. J., P. B. Garland, C. N. Hales & F. A. Newsholme. 1963. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
17. 17. Kim, J. K., J. K. Wi & J. H. Youn. 1996. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45: 446-453.
18. 18. Dresner, A., D. Laurent, M. Marcucci, M. E. Griffin, S. Dufour, G. W. Cline, L. A. Slezak, D. K. Andersen, R. S. Hundal, D. L. Rothman, K. F. Petersen & G. I. ShulMan. 1999. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity [In Process Citation]. J. Clin. Invest. 103: 253-259.
19. 19. Hawkins, M., N. Barzilai, R. Liu, M. Hu, W. Chen & L. Rossetti. 1997. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99: 2173-2182.
20. 20. Roden, M., M. Krssak, H. Stingl, S. Gruber, A. Hofer, C. Furnsinn, E. Moser & W. Waldhausl. 1999. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48: 358-364.
21. 21. Grunfeld, C., K. L. Baird & C. R. Kahn. 1981. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem. Biophys. Res. Commun. 103: 219-226.
22. 22. Svedberg, J., P. Bjorntorp, P. Lonnroth & U. Smith. 1991. Prevention of inhibitory effect of free fatty acids on insulin binding and action in isolated rat hepatocytes by etomoxir. Diabetes 40: 783-786.
23. 23. Svedberg, J., P. Björntorp, U. Smith & P. Lönnroth. 1990. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39: 570-574.
24. 24. Usui, I., Y. Takata, T. Imamura, H. Morioka, T. Sasaoka, T. Sawa, H. Ishihara, M. Ishiki & M. Kobayashi. 1997. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity. Diabetologia 40: 894-901.
25. 25. Schmitz-Peiffer, C. & T. J. Biden. 1998. A cellular model of lipid-induced insulin resistance: investigation of signaling defects and the role of PKC in C2C12 mouse skeletal muscle cells treated with free fatty acid. VII International Symposium on Insulin Receptors and Insulin Action: 72-73.
26. 26. Gerich, J., M. Haymond & R. Rizza. 1981. Hormonal and substrate determinants of hepatic glucose production in man. In The Regulation of Carbohydrate Formation and Utilization in Mammals. C. Veneziale, Ed.: 419. University Park Press. Baltimore, MD.
27. 27. Tessari, P., R. Barazzoni, M. Zanetti, E. Kiwanuka & A. Tiengo. 1996. The role of substrates in the regulation of protein metabolism. Baillieres Clin. Endocrinol. Metab. 10: 511-532.
28. 28. Kimball, S. R., M. Yancisin, R. L. Horetsky & L. S. Jefferson. 1996. Translational and pretranslational regulation of protein synthesis by amino acid availability in primary cultures of rat hepatocytes. Int. J. Biochem. Cell Biol. 28: 285-294.
29. 29. Casetellino, P., L. Luzi, D. C. Simonson, M. Haymond & R. A. DeFronzo. 1987. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J. Clin. Invest. 80: 1784-1793.
30. 30. May, M. E. & M. G. Buse. 1989. Effects of branched-chain amino acids on protein turnover. Diabetes Metab. Rev. 5: 227-245.
31. 31. Louard, R. J., E. J. Barrett & R. A. Gelfand. 1995. Overnight branched-chain amino acid infusion causes sustained suppression of muscle proteolysis. Metabolism 44: 424-429.
32. 32. Flakoll, P. J., L. S. Wentzel, D. E. Rice, J. O. Hill & N. N. Abumrad. 1992. Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability. Diabetologia 35: 357-366.
33. 33. Buckspan, R., B. Hoxworth, E. Cersosimo, J. Devlin, E. Horton & N. Abumrad. 1986. α-Ketoisocaproate is superior to leucine in sparing glucose utilization in humans. Am. J. Physiol. 251: E648-E653.
34. 34. Tappy, L., K. Acheson, S. Normand, D. Schneeberger, A. Thelin, C. Pachiaudi, J. P. Riou & E. Jequier. 1992. Effects of infused amino acids on glucose production and utilization in healthy human subjects. Am. J. Physiol. 262: E826-E833.
35. 35. Abumrad, N. N., R. P. Robinson, B. R. Gooch & W. W. Lacy. 1982. The effect of leucine infusion on substrate flux across the human forearm. J. Surg. Res. 32: 453-463.
36. 36. Pisters, P. W., N. P. Restifo, E. Cersosimo & M. F. Brennan. 1991. The effects of euglycemic hyperinsulinemia and amino acid infusion on regional and whole body glucose disposal. Metabolism 40: 59-65.
37. 37. Ferrannini, E., S. Bevilacqua, L. Lanzone, R. Bonadonna, L. Brandi, M. Oleggini, C. Boni, G. Buzzigoli, D. Ciociaro, L. Luzi & R. A. DeFronzo. 1988. Metabolic interactions of amino acids and glucose in healthy humans. Diab. Nutr. Metab. 3: 175-186.
38. 38. Rossetti, L., D. L. Rothman, R. A. DeFronzo & G. I. Shulman. 1989. Effect of dietary protein on in vivo insulin action and liver glycogen repletion. Am. J. Physiol. 257: E212-E219.
39. 39. Peret, J., S. Foustock, M. Chanez, B. Bois-Joyeux & R. Assan. 1981. Plasma glucagon and insulin concentrations and hepatic phosphoenolpyruvate carboxykinase and pyruvate kinase activities during and upon adaptation of rats to a high protein diet. J. Nutr. 111: 1173-1184.
40. 40. Kettelhut, I. C., M. C. Foss & R. H. Migliorini. 1980. Glucose homeostasis in a carnivorous animal (cat) and in rats fed a high-protein diet. Am. J. Physiol. 239: R437-R444.
41. 41. Brambilla, E., M. E. Patti, I. Terruzzi & L. Luzi. 1996. Amino acids (AA) stimulate protein anabolism via p70 S6 kinase phosphorylation. Diabetes 45(Suppl. 2): 165A.
42. 42. Patti, M. E., E. Brambilla, L. Luzi, E. J. Landaker & C. R. Kahn. 1998. Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 101: 1519-1529.
43. 43. Hotamisligil, G. S., A. Budavari, D. Murray & B. M. Spiegelman. 1994. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94: 1543-1549.
44. 44. Velloso, L. A., F. Folli, X. J. Sun, M. F. White, M. J. A. Saad & C. R. Kahn. 1996. Cross-talk between the insulin and angiotensin signaling system. Proc. Natl. Acad. Sci. U.S.A. 93: 12490-12495.
45. 45. Moxham, C. M. & C. C. Malbon. 1996. Insulin action impaired by deficiency of the G-protein subunit G@Ssiα2. Nature 379: 840-843.
46. 46. Yki-Jarvinen, H., E. Helve & V. A. Koivisto. 1987. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 36: 892-896.
47. 47. Rossetti, L., D. Smith, G. I. Shulman, D. Papachristou & R. A. DeFronzo. 1987. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79: 1510-1515.
48. 48. McClain, D. A. & E. D. Crook. 1996. Hexosamines and insulin resistance. Diabetes 45: 1003-1009.
49. 49. Garvey, W. T., J. M. Olefsky, S. Matthaei & S. Marshall. 1987. Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J. Biol. Chem. 262: 189-197.
50. 50. Marshall, S., V. Bacote & R. R. Traxinger. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266: 4706-4712.
51. 51. Rossetti, L., M. Hawkins, W. Chen, J. Gindi & N. Barzilai. 1995. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemie conscious rats. J. Clin. Invest. 96: 132-140.
52. 52. Robinson, K. A., D. A. Sens & M. G. Buse. 1993. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles: study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes 42: 1333-1346.
53. 53. Baron, A. D., J. S. Zhu, J. H. Zhu, H. Weldon, L. Maianu & W. T. Garvey. 1995. Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle: implications for glucose toxicity. J. Clin. Invest. 96: 2792-2801.
54. 54. Virkamäki, A., M. C. Daniels, S. Hamalainen, T. Utriainen, D. McClain & H. Yki-Järvinen. 1997. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138: 2501-2507.
55. 55. Hawkins, M., N. Barzilai, W. Chen, I. Angelov, M. Hu, P. Cohen & L. Rossetti. 1996. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes 45: 1734-1743.
56. 56. Buse, M. G., K. A. Robinson, T. W. Gettys, E. G. McMahon & E. A. Gulve. 1997. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice. Am. J. Physiol. 272: E1080-E1088.
57. 57. Yki-Jarvinen, H., M. C. Daniels, A. Virkamäki, S. Makimattila, R. A. DeFronzo & D. P. McClain. 1996. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 45: 302-307.
58. 58. Crook, E. D., M. C. Daniels, T. M. Smith & D. A. McClain. 1993. Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts. Diabetes 42: 1289-1296.
59. 59. Hebert, L. F., Jr., M. C. Daniels, J. Zhou, E. D. Crook, R. K. Turner, S. T. Simmons, J. L. Neidigh, J. S. Zhu, A. D. Baron & D. A. McClain. 1996. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98: 930-936.
60. 60. Hawkin, M., N. Barzilai, R. Liu, M. Hu, W. Chen & L. Rossetti. 1997. Role of the gludosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99: 2173-2183.
61. 61. Wang, J., R. Liu, M. Hawkins, N. Barzilai & L. Rossetti. 1998. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688.
62. 62. Chen, H., B. L. Ing, K. A. Robinson, A. C. Feagin, M. G. Buse & M. J. Quon. 1997. Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells. Mol. Cell Endocrinol. 135: 67-77.
63. 63. Hart, G. W., K. D. Greis, L. Y. D. Dong, M. A. Blomberg, T. Y. Chou, M. S. Jiang, E. P. Roquemore, D. M. Snow, L. K. Kreppel, R. N. Cole, E. I. Comer, C. S. Arnold & B. K. Hayes. 1995. O-linked N-acetylglucosamine: The "Yin-Yang" of Ser/Thr phosphorylation? In Glycoimmunology. A. Alavi & J. S. Axford, Eds.: 115. Plenum Press. New York.
64. 64. Ruderman, N. B., A. K. Saha, D. Vavvas, S. J. Heydrick & T. G. Kurowski. 1997. Lipid abnormalities in muscle of insulin-resistant rodents. The malonyl CoA hypothesis. Ann. N.Y. Acad. Sci. 827: 221-230.
65. 65. Saha, A. K., D. Vavvas, T. G. Kurowski, A. Apazidis, L. A. Witters, E. Shafrir & N. B. Ruderman. 1997. NB. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am. J. Physiol. 272: E641-E648.
66. 66. Liu, L., G. B. Karkanias, J. C. Morales, M. Hawkins, N. Barzilai, J. Wang & L. Rossetti. 1998. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273: 31160-31167.
67. 67. Barzilai, N., J. Wang, D. Massilon, P. Vuguin, M. Hawkins & L. Rossetti. 1997. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100: 3105-3110.
68. 68. Wang, J., R. Liu, M. Hawkins, N. Barzilai & L. Rossetti. 1998. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688.
69. 69. Patti, M. E., A. Virkamaki, E. J. Landaker & H. Yki-Jarvinen. 1999. Activation of the hexosamine pathway by glucosamine induces insulin resistance of early post-receptor signaling events in skeletal muscle. Diabetes 48: 1562-1571.